David Vanderweele, MD - 2013 Young Investigator
“The Molecular Characterization of Ductal Adenocarcinoma of the Prostate”
Awarded a $75,000 Cancer Research Foundation Young Investigator Award.
Ductal adenocarcinoma of the prostate is an aggressive subtype that is resistant to standard therapies and is often found coincident with high grade forms of conventional prostate cancer. This proposal characterizes the genetic abnormalities of ductal prostate cancer that is found coincident with conventional prostate cancer, using a number of molecular biology techniques. This study will determine if conventional and ductal prostate cancer are related; that is, if conventional prostate cancer can progress to become a ductal subtype. This work also provides the first catalogue of ductal subtype genetic derangements, laying the groundwork to improve the management of this therapy-resistant disease.
"Thanks to the hard work, commitment, and compassion of scientists, researchers, and organizations like the Cancer Research Foundation, there is renewed hope for discovering better treatments and eventually a cure for cancer.
I commend all of you for your outstanding contributions to the field of cancer research. For five decades, your commitment to the crusade against cancer has given hope and comfort to people across the nation."
Former President of the United States
May 05, 1997